PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Innovator IBD Breakout Opportunities ETF (BOUT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

Issuer

Innovator

Inception Date

Sep 13, 2018

Region

North America (U.S.)

Leveraged

1x

Index Tracked

IBD Breakout Stocks Index

Asset Class

Equity

Asset Class Size

Multi-Cap

Asset Class Style

Blend

Expense Ratio

BOUT features an expense ratio of 0.84%, falling within the medium range.


Expense ratio chart for BOUT: current value at 0.84% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.84%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
BOUT vs. FFTY BOUT vs. SPY BOUT vs. QQQM BOUT vs. VOO BOUT vs. SPMO BOUT vs. QQQ BOUT vs. SCHG BOUT vs. SPYG BOUT vs. SMH
Popular comparisons:
BOUT vs. FFTY BOUT vs. SPY BOUT vs. QQQM BOUT vs. VOO BOUT vs. SPMO BOUT vs. QQQ BOUT vs. SCHG BOUT vs. SPYG BOUT vs. SMH

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Innovator IBD Breakout Opportunities ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
12.50%
5.98%
BOUT (Innovator IBD Breakout Opportunities ETF)
Benchmark (^GSPC)

Returns By Period

Innovator IBD Breakout Opportunities ETF had a return of 0.82% year-to-date (YTD) and 24.77% in the last 12 months.


BOUT

YTD

0.82%

1M

-5.29%

6M

12.50%

1Y

24.77%

5Y*

14.34%

10Y*

N/A

^GSPC (Benchmark)

YTD

-0.22%

1M

-3.00%

6M

5.99%

1Y

24.74%

5Y*

12.68%

10Y*

11.27%

*Annualized

Monthly Returns

The table below presents the monthly returns of BOUT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-0.23%7.26%2.63%-7.35%4.44%-0.99%3.77%1.47%-0.16%0.05%11.61%-4.36%18.14%
20234.08%-1.59%2.83%-1.11%-4.85%10.04%3.40%-5.76%-3.42%-4.37%6.50%8.39%13.27%
2022-10.75%5.88%3.57%-8.13%-1.10%-12.46%5.65%-2.83%-9.38%10.28%1.34%-4.37%-22.60%
20214.27%3.13%-2.53%4.17%-4.90%1.48%2.52%4.09%-3.51%6.67%-0.60%6.65%22.69%
20202.45%-10.27%-4.84%11.87%6.62%1.22%8.73%1.27%-3.23%-0.45%19.47%12.48%50.56%
201910.06%4.85%0.43%2.60%-2.01%3.71%1.44%0.66%-8.76%-0.80%5.19%2.62%20.59%
2018-0.60%-17.30%-2.77%-12.17%-29.80%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BOUT is 61, indicating average performance compared to other ETFs on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BOUT is 6161
Overall Rank
The Sharpe Ratio Rank of BOUT is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of BOUT is 6262
Sortino Ratio Rank
The Omega Ratio Rank of BOUT is 6161
Omega Ratio Rank
The Calmar Ratio Rank of BOUT is 5858
Calmar Ratio Rank
The Martin Ratio Rank of BOUT is 6262
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Innovator IBD Breakout Opportunities ETF (BOUT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for BOUT, currently valued at 1.24, compared to the broader market0.002.004.001.241.88
The chart of Sortino ratio for BOUT, currently valued at 1.76, compared to the broader market-2.000.002.004.006.008.0010.001.762.53
The chart of Omega ratio for BOUT, currently valued at 1.22, compared to the broader market0.501.001.502.002.503.001.221.35
The chart of Calmar ratio for BOUT, currently valued at 1.30, compared to the broader market0.005.0010.0015.001.302.80
The chart of Martin ratio for BOUT, currently valued at 6.35, compared to the broader market0.0020.0040.0060.0080.00100.006.3512.01
BOUT
^GSPC

The current Innovator IBD Breakout Opportunities ETF Sharpe ratio is 1.24. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Innovator IBD Breakout Opportunities ETF with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
1.24
1.88
BOUT (Innovator IBD Breakout Opportunities ETF)
Benchmark (^GSPC)

Dividends

Dividend History

Innovator IBD Breakout Opportunities ETF provided a 0.02% dividend yield over the last twelve months, with an annual payout of $0.01 per share.


0.00%0.20%0.40%0.60%0.80%1.00%1.20%1.40%$0.00$0.10$0.20$0.30$0.402018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM2024202320222021202020192018
Dividend$0.01$0.01$0.44$0.40$0.00$0.00$0.00$0.04

Dividend yield

0.02%0.02%1.32%1.35%0.00%0.00%0.00%0.22%

Monthly Dividends

The table displays the monthly dividend distributions for Innovator IBD Breakout Opportunities ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.01$0.00$0.00$0.00$0.00$0.00$0.01
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.44$0.44
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.40$0.40
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.04$0.04

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-7.12%
-3.64%
BOUT (Innovator IBD Breakout Opportunities ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Innovator IBD Breakout Opportunities ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Innovator IBD Breakout Opportunities ETF was 36.76%, occurring on Mar 20, 2020. Recovery took 95 trading sessions.

The current Innovator IBD Breakout Opportunities ETF drawdown is 7.12%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-36.76%Sep 17, 2018380Mar 20, 202095Aug 5, 2020475
-28.28%Dec 30, 2021187Sep 27, 2022531Nov 6, 2024718
-14.69%Feb 17, 202169May 25, 2021111Nov 1, 2021180
-11.51%Aug 6, 202034Sep 23, 202013Oct 12, 202047
-8.18%Jan 20, 20216Jan 27, 20217Feb 5, 202113

Volatility

Volatility Chart

The current Innovator IBD Breakout Opportunities ETF volatility is 6.42%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%AugustSeptemberOctoberNovemberDecember2025
6.42%
4.13%
BOUT (Innovator IBD Breakout Opportunities ETF)
Benchmark (^GSPC)
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab